UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000003731
Receipt number R000004519
Scientific Title The exploratory analaysis for the efficacy and safety of Rikkunshito for appetite loss during the treatment with PEG-IFN and ribavirin
Date of disclosure of the study information 2010/06/10
Last modified on 2013/06/21 17:57:11

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The exploratory analaysis for the efficacy and safety of Rikkunshito for appetite loss during the treatment with PEG-IFN and ribavirin

Acronym

The analaysis for the efficacy and safety of Rikkunshito for appetite loss during the treatment with PEG-IFN and ribavirin

Scientific Title

The exploratory analaysis for the efficacy and safety of Rikkunshito for appetite loss during the treatment with PEG-IFN and ribavirin

Scientific Title:Acronym

The analaysis for the efficacy and safety of Rikkunshito for appetite loss during the treatment with PEG-IFN and ribavirin

Region

Japan


Condition

Condition

chronic hepatitis C

Classification by specialty

Hepato-biliary-pancreatic medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The analysis for the efficacy and safety of rikkunshito for appetite loss during the treatment with PEG-IFN and ribavirin

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Phase IV


Assessment

Primary outcomes

Appetite loss

Key secondary outcomes

QOL of gastrointestinal symptom
Change of ghrelin and leptin
body weight
Depression


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration

Institution is not considered as adjustment factor.

Blocking


Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Rikkunshito 7.5g per day 2 weeks

Interventions/Control_2

Domperidone 30mg per day 2 weeks

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >=

Gender

Male and Female

Key inclusion criteria

(1) The patients with chronic hepatitis C
(2) During the treatment with PEG-IFN + Ribavirin
(3)Appetite loss

Key exclusion criteria

(1)post gastrectomy
(2)Use of other Kampo medicine
(3)Gastrointestinal bleeding, ilues, perforation of gut

Target sample size

20


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Makoto Arai

Organization

Chiba University Hospital

Division name

gastrointestinal medicine

Zip code


Address

1-8-1 Inohana, Chuo-ku,Chiba City

TEL


Email



Public contact

Name of contact person

1st name
Middle name
Last name

Organization

Chiba University Hospital

Division name

gastrointestinal medicine

Zip code


Address


TEL

043-226-2083

Homepage URL


Email



Sponsor or person

Institute

Department of Gastrointestinal Medicine, Chiba University Hospital

Institute

Department

Personal name



Funding Source

Organization

Department of Gastrointestinal Medicine, Chiba University Hospital

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

千葉大学病院(千葉県)、キッコーマン総合病院(千葉県)


Other administrative information

Date of disclosure of the study information

2010 Year 06 Month 10 Day


Related information

URL releasing protocol


Publication of results

Partially published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2010 Year 04 Month 21 Day

Date of IRB


Anticipated trial start date

2010 Year 07 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2010 Year 06 Month 10 Day

Last modified on

2013 Year 06 Month 21 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000004519


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name